# Effect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD Patients

> **NCT04904952** · NA · UNKNOWN · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 60 (estimated)

## Conditions studied

- OCD

## Interventions

- **DRUG:** N-acetylcysteine tablet 600mg
- **DRUG:** Placebo tablet 600mg

## Key facts

- **NCT ID:** NCT04904952
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-13
- **Primary completion:** 2022-01-10
- **Final completion:** 2022-01-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04904952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04904952, "Effect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04904952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*